Hemostemix files for price protection on C$1 million private placement third tranche units offering
Bitget2026/09/23 20:10- Hemostemix filed a Form 4B seeking price protection for the third tranche of its previously announced non-brokered private placement.
- Offering targets gross proceeds of up to CDN$ 1 million; units include one common share, one-half warrant exercisable at CDN$ 0.12 for 24 months.
- Warrants may face accelerated expiry if the 10-day VWAP reaches at least CDN$ 0.15 following the hold period.
- Expected finder’s fees total about CDN$ 8,000; 80,000 finder warrants issued with a CDN$ 0.06 exercise price.
- Proceeds earmarked for commercialization of ACP-01, manufacturing, Bahamas regulatory filings, working capital; closing remains subject to TSXV acceptance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
